These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dihydrofolate reductase as a target for chemotherapy in parasites. Gangjee A; Kurup S; Namjoshi O Curr Pharm Des; 2007; 13(6):609-39. PubMed ID: 17346178 [TBL] [Abstract][Full Text] [Related]
5. Crystallographic analysis reveals a novel second binding site for trimethoprim in active site double mutants of human dihydrofolate reductase. Cody V; Pace J; Piraino J; Queener SF J Struct Biol; 2011 Oct; 176(1):52-9. PubMed ID: 21684339 [TBL] [Abstract][Full Text] [Related]
6. Molecular modelling of trimethoprim complexes of human wild-type and mutant dihydrofolate reductases: identification of two subsets of binding residues in the antifolate binding site. Pan R; Bowen D; Southerland WM Biopharm Drug Dispos; 1999 Oct; 20(7):335-40. PubMed ID: 10760841 [TBL] [Abstract][Full Text] [Related]
7. Crystal structures of wild-type and mutant methicillin-resistant Staphylococcus aureus dihydrofolate reductase reveal an alternate conformation of NADPH that may be linked to trimethoprim resistance. Frey KM; Liu J; Lombardo MN; Bolstad DB; Wright DL; Anderson AC J Mol Biol; 2009 Apr; 387(5):1298-308. PubMed ID: 19249312 [TBL] [Abstract][Full Text] [Related]
8. Comparative hydrogen-deuterium exchange for a mesophilic vs thermophilic dihydrofolate reductase at 25 °C: identification of a single active site region with enhanced flexibility in the mesophilic protein. Oyeyemi OA; Sours KM; Lee T; Kohen A; Resing KA; Ahn NG; Klinman JP Biochemistry; 2011 Sep; 50(38):8251-60. PubMed ID: 21859100 [TBL] [Abstract][Full Text] [Related]
9. Computational analysis of binding between malarial dihydrofolate reductases and anti-folates. Choowongkomon K; Theppabutr S; Songtawee N; Day NP; White NJ; Woodrow CJ; Imwong M Malar J; 2010 Mar; 9():65. PubMed ID: 20193090 [TBL] [Abstract][Full Text] [Related]
10. Crystal structures of Klebsiella pneumoniae dihydrofolate reductase bound to propargyl-linked antifolates reveal features for potency and selectivity. Lamb KM; Lombardo MN; Alverson J; Priestley ND; Wright DL; Anderson AC Antimicrob Agents Chemother; 2014 Dec; 58(12):7484-91. PubMed ID: 25288083 [TBL] [Abstract][Full Text] [Related]
11. Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis. Nahimana A; Rabodonirina M; Bille J; Francioli P; Hauser PM Antimicrob Agents Chemother; 2004 Nov; 48(11):4301-5. PubMed ID: 15504856 [TBL] [Abstract][Full Text] [Related]
12. Prediction of residues involved in inhibitor specificity in the dihydrofolate reductase family. Goodey NM; Herbert KG; Hall SM; Bagley KC Biochim Biophys Acta; 2011 Dec; 1814(12):1870-9. PubMed ID: 21840427 [TBL] [Abstract][Full Text] [Related]
13. Mycobacterium tuberculosis dihydrofolate reductase reveals two conformational states and a possible low affinity mechanism to antifolate drugs. Dias MV; Tyrakis P; Domingues RR; Paes Leme AF; Blundell TL Structure; 2014 Jan; 22(1):94-103. PubMed ID: 24210757 [TBL] [Abstract][Full Text] [Related]
14. An amino acid substitution in the Babesia bovis dihydrofolate reductase-thymidylate synthase gene is correlated to cross-resistance against pyrimethamine and WR99210. Gaffar FR; Wilschut K; Franssen FF; de Vries E Mol Biochem Parasitol; 2004 Feb; 133(2):209-19. PubMed ID: 14698433 [TBL] [Abstract][Full Text] [Related]
15. Further studies on 2,4-diamino-5-(2',5'-disubstituted benzyl)pyrimidines as potent and selective inhibitors of dihydrofolate reductases from three major opportunistic pathogens of AIDS. Rosowsky A; Forsch RA; Queener SF J Med Chem; 2003 Apr; 46(9):1726-36. PubMed ID: 12699390 [TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics of interactions between rigid and flexible antifolates and dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium falciparum. Mokmak W; Chunsrivirot S; Hannongbua S; Yuthavong Y; Tongsima S; Kamchonwongpaisan S Chem Biol Drug Des; 2014 Oct; 84(4):450-61. PubMed ID: 24716467 [TBL] [Abstract][Full Text] [Related]
17. Fragment-based design of symmetrical bis-benzimidazoles as selective inhibitors of the trimethoprim-resistant, type II R67 dihydrofolate reductase. Bastien D; Ebert MC; Forge D; Toulouse J; Kadnikova N; Perron F; Mayence A; Huang TL; Vanden Eynde JJ; Pelletier JN J Med Chem; 2012 Apr; 55(7):3182-92. PubMed ID: 22424148 [TBL] [Abstract][Full Text] [Related]
19. Elucidating features that drive the design of selective antifolates using crystal structures of human dihydrofolate reductase. Lamb KM; G-Dayanandan N; Wright DL; Anderson AC Biochemistry; 2013 Oct; 52(41):7318-26. PubMed ID: 24053334 [TBL] [Abstract][Full Text] [Related]
20. A glutamine 67--> histidine mutation in homotetrameric R67 dihydrofolate reductase results in four mutations per single active site pore and causes substantial substrate and cofactor inhibition. Park H; Bradrick TD; Howell EE Protein Eng; 1997 Dec; 10(12):1415-24. PubMed ID: 9543003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]